Company description

FAREVA is a global pharmaceutical and API leading CDMO with 41 production sites located in 12 countries (Europe, Russia, Turkey, Americas) with 12 000 employees, with a Pharma Sector that specializes in the development, commercialization, and launch of API and Drug Product. FAREVA’s API group has industry leading expertise in the areas of development & optimization of complex synthesis, HP-API, aseptic processing, cryogenic, hydrogenation, steroids, spray drying, PSD and polymorph control with volumes ranging from 10 kg to 250 MT. Fareva is the first and only company in the world to receive SafeBridge Certification to handle both high potent drug substance and drug product at the same facility. Our Drug Product and Formulations group specializes in sterile solutions / suspensions, lyophilization, tablets, capsules, sprays / aerosols, liquids / gels, powder filling, blow fill seal, suppositories, and high potent oral formulations. All sites are FDA / EU approved and our packaging is fully serialized to meet the newest regulations.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: Anti-counterfeit |API Contract Manufacturing |Contract Manufacturing More

Upcoming events

13 oct 2020

CPhI Worldwide 2020

13 - 15 October 2020 Milan, Italy Visit us at stand 4H20 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 121D20 See our Exhibitor Profile   See full Exhibitor List

Contact information




View all contact information